Skip to main content
. 2024 Jun 28;75:103256. doi: 10.1016/j.redox.2024.103256

Fig. 4.

Fig. 4

Representative copper chelators currently in the clinics or in development for clinical use. Structures were illustrated by using ChemDraw Professional, Revity Signals Software. Sources: BAL [214], d-penicillamine [220], trientine [231], Chel2 [256], DPA-based chelator [258], DMP-1001 [259], methanobactins Ob3B and SB2 [264].